Sodium nitroprusside
USP/1614501 - United States Pharmacopeia (USP) Reference Standard
Synonym: Sodium nitroferricyanide(III) dihydrate; Nitroprusside sodium; SNP; Sodium nitroprusside; Sodium pentacyanonitrosylferrate
CAS Number: 13755-38-9
Empirical Formula (Hill Notation): C5FeN6Na2O · 2H2O
Molecular Weight: 297.95
MDL Number: MFCD00149192
Linear Formula: Na2[Fe(CN)5NO] · 2H2O
Product Type: Chemical
| API family | sodium nitroprusside |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/5CN.Fe.NO.2Na.2H2O/c5* |
| InChI key | OIRZWVYIQXBRFC-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | [Na+].[Na+].[H]O[H].[H]O[ |
| storage temp. | 2-8°C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Sodium nitroprusside USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Sodium Nitroprusside for Injection |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: | 2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research |
| Other Notes: | Sales restrictions may apply. |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| RIDADR | UN 3288 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 41116107 |